Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI once daily versus usual maintenance therapy for asthma in UK primary care
2011-005553-31Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluticasone and vilanterol in asthma (2 arms), sponsored by GSK. Primary endpoint: Asthma Control Test response at Week 24. Started Apr 2012; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-005553-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005553-31.